Results 241 to 250 of about 4,908,366 (272)
Some of the next articles are maybe not open access.
Accelerated corneal collagen cross-linking for progressive keratoconus
Cutaneous and Ocular Toxicology, 2013To evaluate the efficacy of accelerated corneal cross-linking (CXL) procedure for progressive keratoconus.Twenty-three eyes of 23 patients undergone accelerated CXL procedure were evaluated preoperatively and postoperatively at 1st, 3rd and 6th month for uncorrected distant visual acuity (UDVA), best corrected distant visual acuity (CDVA), spherical ...
Yasin, Cınar +7 more
openaire +2 more sources
Conventional Versus Accelerated Collagen Cross-Linking for Keratoconus
Eye & Contact Lens: Science & Clinical Practice, 2015: Collagen cross-linking (CXL) is a procedure that primarily aims to increase corneal stiffness. Although used for a variety of conditions, it is most commonly applied to the treatment of keratoconus. Collagen cross-linking involves irradiation of the cornea with ultraviolet A (UVA) irradiation after it has been soaked with riboflavin (vitamin B), a ...
Aris, Konstantopoulos, Jodhbir S, Mehta
openaire +2 more sources
Long-Term Results of Accelerated and Conventional Corneal Cross-Linking
International Ophthalmology, 2020The aim of this study is to compare the long-term follow-up outcomes of traditional and accelerated corneal cross-linking (CXL) for keratoconus.This retrospective comparative cohort study included patients with keratoconus who underwent corneal cross-linking (CXL) between August 2008 and December 2016.
Samara Barbara Marafon
exaly +3 more sources
Isotonic Riboflavin and HPMC With Accelerated Cross-Linking Protocol
Cornea, 2014The aim of this study was to monitor corneal pachymetry changes during accelerated collagen cross-linking (CXL) for keratoconus while using isotonic riboflavin with HPMC.All consecutive patients who underwent CXL for progressive keratoconus, using accelerated protocol and isotonic riboflavin with HPMC, from December 2012 to September 2013 were included
Vandana, Jain +2 more
openaire +2 more sources
Accelerated Corneal Cross-Linking
2018Purpose: Corneal cross-linking (CXL) is a relatively new treatment that offers refractive stability in patients with corneal ectatic disorders. The conventional Dresden protocol has been firstly described, and its effectiveness has been demonstrated by several clinical trials.
Leopoldo Spadea +3 more
openaire +2 more sources
Scotopic Contrast Sensitivity and Glare After Accelerated Corneal Cross‐Linking [PDF]
The aim was to assess one-year changes in uncorrected and corrected contrast sensitivity (CS) and glare under scotopic conditions after accelerated cross-linking (CXL) using the 18 mW/cm2 protocol for the treatment of progressive keratoconus and compare results with unoperated controls.In this non-randomised clinical trial, 30 eyes were enrolled in the
Hassan Hashemi +2 more
exaly +3 more sources
Myasthenic Antibodies Cross-Link Acetylcholine Receptors to Accelerate Degradation
New England Journal of Medicine, 1978The decrease of acetylcholine receptors at neuromuscular junctions of myasthenic patients has been attributed to an antibody-mediated autoimmune process that accelerates receptor degradation. We studied the mechanism of this process in skeletal-muscle cultures, using intact antibodies and antibody fragments.
D B, Drachman +4 more
openaire +2 more sources
Principles of Accelerated Corneal Collagen Cross-Linking
2017Prior to the advent of the corneal collagen cross-linking procedure, no conservative treatment for corneal ectasia existed, with 20% of keratoconus patients progressing to eventually require penetrating keratoplasty [1].
Cosimo Mazzotta +5 more
openaire +1 more source
Accelerated Corneal Collagen Cross-Linking in Thin Keratoconic Corneas
Journal of Refractive Surgery, 2015PURPOSE: To report the outcomes of accelerated corneal collagen cross-linking in patients with thin corneas (minimum corneal thickness < 400 µ m). METHODS: Thirty-four eyes of 34 patients with a minimum ...
Engin Bilge, Ozgurhan +4 more
openaire +2 more sources

